Clinical trials
Disease clinical trials
Below are recruiting disease clinical trials, each written for real people, not researchers. We’re tracking 9,583 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT03277365Recruiting
Share your 23andMe data with a digital genetics study
This study tests a digital platform that uses people’s existing genetic information to support genetic research. If you are an adult and willing to share your 23andMe results from an Apple phone, you can likely participate.
La Jolla, CaliforniaAges 18 years+ - NCT03293758Recruiting
Study of food and gut bacteria changes over time
This study looks at how your diet affects the mix of gut bacteria over time. It may help researchers understand links between food, microbiome (gut bacteria), and health outcomes.
New York, New YorkAges 40 years+ - NCT03301038RecruitingPhase 2
Rifampin for a rare calcium disorder caused by CYP24A1
This trial tests rifampin to improve high blood and/or urine calcium that happens in people with CYP24A1 gene changes. It also checks safety by watching liver and kidney blood tests and pregnancy status.
Philadelphia, PennsylvaniaAges 6 months–65 years - NCT03298334RecruitingPhase 1/Phase 2
Testing vaginal bacteria transfer to newborns after C-section
This study looks at whether they can safely place “healthy vaginal bacteria” from the mother into the newborn after a scheduled C-section, and whether it improves the baby’s health. It only enrolls certain mothers and babies based on infection testing and other health factors.
Falls Church, VirginiaAges birth–50 years - NCT03299608Recruiting
Breath test to quickly detect infections in blood cancer patients
This study tests whether a quick breath test can detect infections early in people receiving intensive treatment for certain blood cancers or bone marrow transplant patients. If it works, it could help doctors find infections faster and adjust treatment sooner.
LeuvenAges 18 years+ - NCT03305835Recruiting
Genetic testing for inherited kidney stone causes
This study uses genetic testing to look for inherited (“monogenic”) reasons some people get kidney stones. It may help explain the cause of stones and calcium-related problems, which can guide future care for you or your family.
Rochester, MinnesotaAges Any age - NCT03308916Recruiting
Screening for liver scarring risk using noninvasive tests
This study checks people who are at higher risk for liver scarring by using noninvasive tests. If those tests suggest significant scarring, the study may consider further testing, but not everyone will need a biopsy.
OdenseAges 30–75 - NCT03326921RecruitingPhase 1
T cell treatment for leukemia after a bone marrow transplant
This early-phase trial tests an immune “T cell” therapy made to recognize a specific leukemia target. It is for people whose acute leukemia has come back (relapsed) or did not fully respond after receiving a donor stem cell transplant.
Seattle, WashingtonAges Up to 80 years - NCT03321656RecruitingPhase 2/Phase 3
Envarsus XR after kidney transplant to reduce hidden rejection
This study looks at whether Envarsus XR helps prevent “subclinical” (not obviously noticeable) kidney transplant rejection by changing blood immune test results. You may be able to join if you recently received a kidney transplant and can take the study medicine as required.
Lexington, KentuckyAges 18–75 - NCT03327961Recruiting
Study of implanted scaffolds with follow-up in adults
This study follows adults who have had at least one scaffold placed to see how they do over time. It also looks at whether people can stick with the required anti-platelet medicines for at least a year, and whether they can be followed for a year.
Agrigento, AgrigentoAges 18 years+ - NCT03327779Recruiting
Bleeding disorders registry for blood-clotting conditions
This study is a registry that collects information about people with bleeding disorders like hemophilia A or B and von Willebrand disease. The goal is to better understand these conditions and improve care across participating treatment centers.
Montreal, QuebecAges Any age - NCT03331133Recruiting
Study of twins born in Guangzhou
This study focuses on twins who were born at Guangzhou Women and Children’s Medical Center. It aims to use pregnancy and baseline information to learn about twin outcomes and care, and it may help local doctors improve guidance for families in Guangzhou.
Guangzhou, GuangdongAges Up to 18 years - NCT03331302RecruitingPhase 1/Phase 2
Tested lung imaging scans in stable COPD patients
This study compares two ways of seeing how well your lungs work: a special MRI scan and another scan that uses a different gas. It may help researchers find which imaging test best reflects lung function in people with COPD.
Charlottesville, VirginiaAges 18 years+ - NCT03337932Recruiting
Shorter doxycycline course for multiple early Lyme skin rashes
This study looks at how long to take doxycycline for people who have multiple early Lyme disease skin rashes. It may help find the shortest effective treatment duration while keeping side effects low.
LjubljanaAges 18 years+ - NCT03335644Recruiting
Internet-based health study for people 15 and older
This study gathers health information through an online program. It may help researchers understand how diet and lifestyle affect health over time.
Bobigny, Seine Saint DenisAges 15 years+ - NCT03348501Recruiting
MEN1 monitoring study for people in France
This study follows people with Multiple Endocrine Neoplasia type 1 (MEN1) over time, including those with symptoms, certain isolated hormone gland problems, and people without symptoms who have the MEN1 gene change. It may help doctors learn how MEN1 starts and progresses so care can be better timed and personalized.
DijonAges Any age - NCT03361215Recruiting
Tracking skin disease patterns and anti-inflammatory response
This study looks at how atopic dermatitis (eczema), psoriasis, or other autoimmune skin diseases change over time and how the body responds to anti-inflammatory signals. Your information and—if eligible—samples help researchers find patterns that could guide better treatments.
KielAges birth–100 years - NCT03372980Recruiting
Study registry of blood tests for Takayasu arteritis
This study collects information and blood samples (biomarkers) to better understand Takayasu arteritis and how active it is. It may help researchers find tests that support diagnosis and track disease activity.
Beijing, Beijing MunicipalityAges 18–70 - NCT03378934RecruitingPhase 4
Berberine after stent placement to reduce blood-platelet effects
This trial studies whether berberine changes how strongly your platelets “stick together” after a coronary stent. It may help reduce risk related to clotting while you continue standard heart medicines (aspirin and clopidogrel).
Beijing, Beijing MunicipalityAges 18–70 - NCT03384537RecruitingEarly Phase 1
Tropolone mouthwash test in healthy adults
This early trial compares a mouthwash that contains tropolone versus a mouthwash without tropolone to see how well each works against germs in the mouth. You may be asked to pause your usual mouth-cleaning routine for a few days beforehand.
CairoAges 18–45 - NCT03386981Recruiting
Study of bone health patterns in healthy adult athletes
This study looks at what bone “profiles” look like in healthy adult athletes. It may help researchers better understand how normal bone health varies in people who are physically active.
MilanAges 18 years+ - NCT03394313Recruiting
Registry study for people with new heart disease and type 2 diabetes
This study records health information to understand how type 2 diabetes and newly diagnosed heart disease affect people over time. It may help doctors learn what to watch for and how to plan care, though it is mainly an observational registry.
DohaAges 18 years+ - NCT03418441Recruiting
Study infections of the brain and spinal fluid in Denmark
This trial focuses on people in Denmark who may have an infection in the brain or the fluid around the brain and spinal cord. Researchers aim to collect and compare diagnostic results for different infection types (viral meningitis, bacterial meningitis, encephalitis, and others) to help confirm the cause and guide care.
AalborgAges 18 years+ - NCT03425526RecruitingPhase 1
Donor T-cell treatment for adenovirus illness in immune-weakened people
This early-phase study tests donor immune cells (T cells) to treat people who have adenovirus infection or adenovirus-related disease but have a weakened immune system. It may help your body fight the virus, especially in cases where other treatments may not be enough.
Houston, TexasAges Any age
Hear when a new Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for disease?
- Yes. Clin2 currently lists 9,583 recruiting disease studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a disease trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a disease trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.